Karen Linehan
Fortuna: 226 356 $ al 31/05/2026
Fortuna: 226 356 $ al 31/05/2026
Karen Linehan is currently an Independent Non-Executive Director at CNH Industrial NV since 2022, a Non-Executive Director at Global Antibiotic Research & Development Partnership, an Independent Director at Aelis Farma SA since 2022, a Member of the Supervisory Board at Sanofi-Aventis Deutschland GmbH, a Member of the Supervisory Board at Hoechst GmbH, and a Member of the Visitors Board at Georgetown University Law Center.
Former roles include Independent Non-Executive Director at VEON Ltd. from 2022 to 2024, Executive VP-Legal Affairs & General Counsel at Sanofi from 2014 to 2021, Associate at Townley & Updike from 1986 to 1990, and Member of the Supervisory Board at EUROAPI SA. Education includes undergraduate and graduate degrees from Georgetown University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 26/05/2026 | 22.170 ( 0 % ) | 226 356 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AELIS FARMA | Director/Miembro de la Junta | 01/01/2022 |
| CNH INDUSTRIAL N.V. | Director/Miembro de la Junta | 11/03/2022 |
Hoechst GmbH
Hoechst GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells drugs | Director/Miembro de la Junta | - |
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products & provides research and development services | Director/Miembro de la Junta | - |
Global Antibiotic Research & Development Partnership
Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Provides research and development for biological products | Director/Miembro de la Junta | - |
Georgetown University Law Center
Georgetown University Law Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| VEON LTD. | Director/Miembro de la Junta | 31/05/2024 |
| SANOFI | Consejero General | 31/12/2021 |
| EUROAPI | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products & provides research and development services | Health Technology |
VEON Ltd.
VEON Ltd. Wireless TelecommunicationsCommunications Provides wireless telecommunications services | Communications |
Hoechst GmbH
Hoechst GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells drugs | Health Technology |
CNH Industrial NV
CNH Industrial NV Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures and markets agricultural and construction equipment | Producer Manufacturing |
Georgetown University Law Center
Georgetown University Law Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aelis Farma SA
Aelis Farma SA BiotechnologyHealth Technology Operates as a biotechnology company which develops drugs for brain diseases | Health Technology |
Global Antibiotic Research & Development Partnership
Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Provides research and development for biological products | Health Technology |
EUROAPI SA
EUROAPI SA BiotechnologyHealth Technology Develops, manufactures, markets and distributes small molecule APIs | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.